HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tolerability of rifampin monotherapy for latent tuberculosis infection in children.

AuthorsIrini Daskalaki, Jaehyun Byun, M Christina Dogbey, Cymara Tolbert-Warren, Barbara M Watson
JournalThe Pediatric infectious disease journal (Pediatr Infect Dis J) Vol. 30 Issue 11 Pg. 1014-5 (Nov 2011) ISSN: 1532-0987 [Electronic] United States
PMID21997666 (Publication Type: Letter)
Chemical References
  • Antitubercular Agents
  • Isoniazid
  • Rifampin
Topics
  • Adolescent
  • Antitubercular Agents (administration & dosage, therapeutic use)
  • Child
  • Drug Administration Schedule
  • Drug Dosage Calculations
  • Humans
  • Isoniazid (administration & dosage, adverse effects, therapeutic use)
  • Latent Tuberculosis (drug therapy, epidemiology, microbiology)
  • Mycobacterium tuberculosis (drug effects, physiology)
  • Patient Compliance
  • Rifampin (administration & dosage, therapeutic use)
  • United States (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: